Trial Information

Summary: Relapsed or Refractory Multiple Myeloma - Adults

People with multiple myeloma (cancer of the plasma cells in bone marrow) are asked to participate in a research study being conducted by North Shore University Hospital.

You may be eligible to participate in this study if you:

• Are at least 18 years of age
• Have been diagnosed with relapsed or refractory multiple myeloma

You may not participate in this study if you:

• Have had a dose of chemotherapy, biological, immunotherapy, investigational agent (therapeutic or diagnostic) no less than 28 days before receipt of study drug
• Have been diagnosed with another malignancy unless disease free for more than 1 year
• Have known active hepatitis A, B, or C, or are human immunodeficiency virus (HIV) positive
• Have cardiac disease
• Have incomplete recovery from any prior surgical procedures or had surgery within 4 weeks before study entry
• Have an active infection
• Are pregnant, breastfeeding, or intend to become pregnant during the study
• Have participated in another research study within the last 30 days

If you would like to learn more about participating in this study, please send an e-mail message using the form below.